Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec;54(12):1513-9.
doi: 10.1007/s00108-013-3337-1.

[Drug therapy of infectious diarrhea. Part 2: Chronic diarrhea]

[Article in German]
Affiliations
Review

[Drug therapy of infectious diarrhea. Part 2: Chronic diarrhea]

[Article in German]
C Lübbert et al. Internist (Berl). 2013 Dec.

Abstract

Diarrheal diseases are among the most common diseases worldwide. In this review the current treatment recommendations for acute (Part 1) and chronic (Part 2) infectious diarrhea are summarized and typical enteropathogens are discussed. The second part of the article describes chronic diarrhea, its related pathogens and treatment. In contrast to acute diarrhea which is mainly caused by viral and typical bacterial pathogens, chronic diarrhea has mainly non-infectious origins. Protozoal pathogens, such as Giardia lamblia and Entamoeba histolytica in particular are found and more rarely bacterial pathogens, such as Tropheryma whipplei. Opportunistic pathogens cause diarrhea in immunocompromised patients, such as in HIV patients. In these patients cytomegalovirus (CMV) colitis or infections with Cryptosporidium spp., Cyclospora cayetanensis, Isospora belli or microsporidia have to be considered. Besides targeted specific antimicrobial therapy, anti-retroviral drugs improving the underlying immunosuppression and thus the reconstitution of the adaptive immune response remain a cornerstone of the treatment in HIV-positive patients.

PubMed Disclaimer

Similar articles

Cited by

  • [Gastrointestinal infections].
    Lübbert C, Mutters R. Lübbert C, et al. Internist (Berl). 2017 Feb;58(2):149-169. doi: 10.1007/s00108-016-0183-y. Internist (Berl). 2017. PMID: 28116471 Review. German.

References

    1. Emerg Infect Dis. 2010 May;16(5):776-82 - PubMed
    1. N Engl J Med. 2013 May 9;368(19):1817-25 - PubMed
    1. Lancet. 2003 Mar 22;361(9362):1025-34 - PubMed
    1. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004932 - PubMed
    1. Med Mal Infect. 2010 Jul;40(7):371-82 - PubMed

MeSH terms

LinkOut - more resources